Tridandapani S - Search Results

1

A Phase I/II Trial of Cetuximab in Combination with Interleukin-12 Administered to Patients with Unresectable Primary or Recurrent Head and Neck Squamous Cell Carcinoma.

McMichael EL, Benner B, Atwal LS, Courtney NB, Mo X, Davis ME, Campbell AR, Duggan MC, Williams K, Martin K, Levine K, Olaverria Salavaggione GN, Noel T, Ganju A, Uppati S, Paul B, Olencki T, Teknos TN, Savvides P, Tridandapani S, Byrd JC, Caligiuri MA, Liu SV, Carson WE 3rd. McMichael EL, et al. Among authors: tridandapani s. Clin Cancer Res. 2019 Aug 15;25(16):4955-4965. doi: 10.1158/1078-0432.CCR-18-2108. Epub 2019 May 29. Clin Cancer Res. 2019. PMID: 31142501 Free PMC article. Clinical Trial.

2

TGF-beta 1 suppresses [correction of supresses] myeloid Fc gamma receptor function by regulating the expression and function of the common gamma-subunit.

Tridandapani S, Wardrop R, Baran CP, Wang Y, Opalek JM, Caligiuri MA, Marsh CB. Tridandapani S, et al. J Immunol. 2003 May 1;170(9):4572-7. doi: 10.4049/jimmunol.170.9.4572. J Immunol. 2003. PMID: 12707335

3

Differential expression of SHIP1 in CD56bright and CD56dim NK cells provides a molecular basis for distinct functional responses to monokine costimulation.

Trotta R, Parihar R, Yu J, Becknell B, Allard J 2nd, Wen J, Ding W, Mao H, Tridandapani S, Carson WE, Caligiuri MA. Trotta R, et al. Among authors: tridandapani s. Blood. 2005 Apr 15;105(8):3011-8. doi: 10.1182/blood-2004-10-4072. Epub 2004 Dec 16. Blood. 2005. PMID: 15604218 Free article.

4

Src homology 2-containing inositol 5'-phosphatase 1 negatively regulates IFN-gamma production by natural killer cells stimulated with antibody-coated tumor cells and interleukin-12.

Parihar R, Trotta R, Roda JM, Ferketich AK, Tridandapani S, Caligiuri MA, Carson WE 3rd. Parihar R, et al. Among authors: tridandapani s. Cancer Res. 2005 Oct 1;65(19):9099-107. doi: 10.1158/0008-5472.CAN-04-4424. Cancer Res. 2005. PMID: 16204085

5

Alemtuzumab induces caspase-independent cell death in human chronic lymphocytic leukemia cells through a lipid raft-dependent mechanism.

Mone AP, Cheney C, Banks AL, Tridandapani S, Mehter N, Guster S, Lin T, Eisenbeis CF, Young DC, Byrd JC. Mone AP, et al. Among authors: tridandapani s. Leukemia. 2006 Feb;20(2):272-9. doi: 10.1038/sj.leu.2404014. Leukemia. 2006. PMID: 16341049

6

Natural killer cells produce T cell-recruiting chemokines in response to antibody-coated tumor cells.

Roda JM, Parihar R, Magro C, Nuovo GJ, Tridandapani S, Carson WE 3rd. Roda JM, et al. Among authors: tridandapani s. Cancer Res. 2006 Jan 1;66(1):517-26. doi: 10.1158/0008-5472.CAN-05-2429. Cancer Res. 2006. PMID: 16397268

7

FcgammaR-induced production of superoxide and inflammatory cytokines is differentially regulated by SHIP through its influence on PI3K and/or Ras/Erk pathways.

Ganesan LP, Joshi T, Fang H, Kutala VK, Roda J, Trotta R, Lehman A, Kuppusamy P, Byrd JC, Carson WE, Caligiuri MA, Tridandapani S. Ganesan LP, et al. Among authors: tridandapani s. Blood. 2006 Jul 15;108(2):718-25. doi: 10.1182/blood-2005-09-3889. Epub 2006 Mar 16. Blood. 2006. PMID: 16543474 Free PMC article.

8

Interleukin-21 enhances NK cell activation in response to antibody-coated targets.

Roda JM, Parihar R, Lehman A, Mani A, Tridandapani S, Carson WE 3rd. Roda JM, et al. Among authors: tridandapani s. J Immunol. 2006 Jul 1;177(1):120-9. doi: 10.4049/jimmunol.177.1.120. J Immunol. 2006. PMID: 16785506

9

Targeting CD37-positive lymphoid malignancies with a novel engineered small modular immunopharmaceutical.

Zhao X, Lapalombella R, Joshi T, Cheney C, Gowda A, Hayden-Ledbetter MS, Baum PR, Lin TS, Jarjoura D, Lehman A, Kussewitt D, Lee RJ, Caligiuri MA, Tridandapani S, Muthusamy N, Byrd JC. Zhao X, et al. Among authors: tridandapani s. Blood. 2007 Oct 1;110(7):2569-77. doi: 10.1182/blood-2006-12-062927. Epub 2007 Apr 17. Blood. 2007. PMID: 17440052 Free PMC article.

10

The activation of natural killer cell effector functions by cetuximab-coated, epidermal growth factor receptor positive tumor cells is enhanced by cytokines.

Roda JM, Joshi T, Butchar JP, McAlees JW, Lehman A, Tridandapani S, Carson WE 3rd. Roda JM, et al. Among authors: tridandapani s. Clin Cancer Res. 2007 Nov 1;13(21):6419-28. doi: 10.1158/1078-0432.CCR-07-0865. Epub 2007 Oct 25. Clin Cancer Res. 2007. PMID: 17962339

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

192 results

Search Page